University of Michigan Rogel Cancer Center: all 322 studies

Page 4 of 4. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.

• Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the ProstateCompletedNCT00151060Phase 2
• Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerCompletedNCT00151047Phase 2
• Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
• Tetrathiomolybdate in Hormone Refractory Prostate CancerCompletedNCT00150995Phase 2
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteTerminatedNCT00148135Phase 2
• Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast CancerCompletedNCT00148070Phase 2
• Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the BloodCompletedNCT00146055Phase 2
• UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast CancerCompletedNCT00146042Phase 2
• Companion Pharmacogenetic Study to UMCC 9900/9901TerminatedNCT00146029
• Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the BloodTerminatedNCT00143884Phase 2
• Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's LymphomaCompletedNCT00143871Phase 2
• The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host DiseaseCompletedNCT00141713Phase 2
• Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's LymphomaTerminatedNCT00141700Phase 2
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderCompletedNCT00136175Phase 2
• Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple MyelomaCompletedNCT00135187Not applicable
• Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate CancerCompletedNCT00134355Phase 2
• Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple MyelomaCompletedNCT00116961Phase 2
• UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for CancerCompletedNCT00064272Phase 2
• Curcumin for the Prevention of Colon CancerCompletedNCT00027495Phase 1
• Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00005598Phase 2
• UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical NeoplasiaCompletedNCT00003598Not applicable
• Eflornithine to Prevent Cancer in Patients With Barrett's EsophagusCompletedNCT00003076Phase 2

← University of Michigan Rogel Cancer Center overview and focus areas